Oral l-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men
- 31 October 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 26 (4) , 1054-1061
- https://doi.org/10.1016/0735-1097(95)00257-9
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The role of nitric oxide and cGMP in platelet adhesion to vascular endotheliumPublished by Elsevier ,2005
- Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans.Circulation, 1994
- Is NO an endogenous antiatherogenic molecule?Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.Journal of Clinical Investigation, 1992
- Regulatory Functions of the Vascular EndotheliumNew England Journal of Medicine, 1990
- Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilatorBritish Journal of Pharmacology, 1988
- In vivo EDRF activity influences platelet functionBritish Journal of Pharmacology, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Stimulation of soluble guanylate cyclase by endothelium-derived relaxing factor from cultured endothelial cellsEuropean Journal of Pharmacology, 1987
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980